New CAR t therapy takes on Hard-to-Treat solid tumors
Disease control
Recruiting now
This early-stage trial tests a new treatment called LEU011 for people with solid tumors that have not responded to standard therapies or have returned. LEU011 uses a patient's own immune cells, modified to better recognize and attack cancer cells. The main goals are to check safe…
Phase: PHASE1, PHASE2 • Sponsor: Leucid Bio • Aim: Disease control
Last updated May 15, 2026 11:53 UTC